Worth Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Worth Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-645	Closed	-$98.8K	–	197
2023 Q2	$98.8K	Sell	645 -178	-22%	-$27.8K	0.08%	140
2023 Q1	$128K	Buy	+823	New	+$129K	0.1%	113

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Worth Asset Management's FBT Position: Q3 2023 in Review

Worth Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2023, closing a stake of 645 shares — an estimated $98.8K sold.

Worth Asset Management first reported a position in FBT in Q1 2023 and held it in 2 quarters. The position peaked at $128K in Q1 2023. 242 funds tracked by Wall St. Rank hold FBT as of Q3 2023.

Worth Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2023 after selling out during the quarter.
Worth Asset Management sold 645 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2023, an estimated $98.8K.
Worth Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and held it in 2 quarters.
Worth Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $128K in Q1 2023.
242 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.